Le Lézard
Classified in: Health, Science and technology
Subject: CALENDAR OF EVENTS

Epic Bio to Present at the Upcoming CRISPR2.0 Conference


SOUTH SAN FRANCISCO, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced a presentation at the upcoming CRISPR2.0 conference being held November 28-30, 2023, at the Hilton Boston Back Bay, Boston Massachusetts.

Title: GEMS: CRISPR Epigenetics Platform to Revolutionize Genetic Medicine
Track: Tech Innovation
Session: Epigenetics: Harnessing Nature's Mechanism for Genome Regulation
Session Date: Wednesday, November 29, 2023
Presentation Time: 1:30 p.m. ET

Learn more about CRISPR2.0 and register to participate here: https://crispr-conference.com/

About Epic Bio
Epic Bio is a leading epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company's proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells, enabling in vivo or ex vivo delivery via a single viral vector. Epic's lead program, EPI-321, is in IND-enabling studies for the treatment of facioscapulohumeral muscular dystrophy (FSHD); additional programs seek to address alpha-1 antitrypsin deficiency (A1AD), heterozygous familial hypercholesterolemia (HeFH), and other indications. Visit www.epic-bio.com for more information or follow us on Twitter and LinkedIn

Investor Contact

Shawn M. Cox
Epic Bio
Manager, Investor Relations, and Corporate Communications
[email protected]

Media Contact

Lisa Raffensperger
Ten Bridge Communications
[email protected]
(617) 903-8783



These press releases may also interest you

at 02:23
Chinese President Xi Jinping on multiple occasions highlighted the Chinese tradition of strong family ties, especially mother's caring, and its importance to people's wellbeing and the national development.Ahead of the Mother's Day that falls on May...

at 02:20
EACON Mining has once again demonstrated its expertise in the field of opencast coal mining with the 6th  AHS contract. The latest project is the Shitoumei coal mine with reserves of 10 billion tons and an annual production capacity of over 15...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 14, 2024 - Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), is pleased to...

at 02:15
The whitepaper explores document generation tools that help organizations transition from manual to automated processes and enhance efficiency, accuracy, and productivity. It details the features of the Power Platform, a user-friendly, low-code...

at 02:13
TCT Asia 2024, held from May 7th to 9th at the NECC in Shanghai, was a resounding success, with UnionTech, a leader in China's additive manufacturing sector, making a notable impact by showcasing its latest 3D printing systems and comprehensive AM...

at 02:05
The Swiss GRC Day 2024, which recently took place at the Radisson Blu Hotel at Zurich Airport, attracted over 300 governance, risk and compliance (GRC) professionals. This year's conference focused on forward-looking and timely corporate governance...



News published on and distributed by: